The FDA in July appointed Dr. George Tidmarsh as the nation's top drug official. Since then, the Center for Drug Evaluation and Research (CDER) has seen two additional senior staff members in the five months since then. Thus, in total, CDER has had five leaders in one year. The FDA's Center for Drug Products thus enters 2026 at a crossroads. The report tracks these leadership changes.